Omnimmune Financial Statements From 2010 to 2026

OMMH Stock  USD 0.0001  0.00  0.00%   
Omnimmune Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Omnimmune Holdings' valuation are provided below:
Market Capitalization
980
Earnings Share
(0.01)
We have found eighty-two available trending fundamental ratios for Omnimmune Holdings, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Omnimmune Holdings recent fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to 785.70. Enterprise Value is estimated to decrease to about 1.1 M
Check Omnimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnimmune Holdings' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Omnimmune financial statements analysis is a perfect complement when working with Omnimmune Holdings Valuation or Volatility modules.
  
Build AI portfolio with Omnimmune Stock
Check out the analysis of Omnimmune Holdings Correlation against competitors.
For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.

Omnimmune Holdings Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets30.1 K36.1 K30 K
Slightly volatile
Total Current Liabilities2.3 MMM
Pretty Stable
Accounts Payable1.1 MM873.1 K
Slightly volatile
Cash6.1 K6.5 K5.6 K
Slightly volatile
Long Term Debt1.1 M929.6 K1.1 M
Slightly volatile
Other Current Assets16.5 K28.8 K23.8 K
Pretty Stable
Total Liabilities3.2 M4.9 MM
Pretty Stable
Short and Long Term Debt892.3 K888.3 K1.1 M
Slightly volatile
Total Current Assets30.1 K36.1 K30 K
Slightly volatile
Short Term Debt892.3 K888.3 K1.1 M
Slightly volatile
Common Stock761801K
Slightly volatile
Other Stockholder Equity972K53.4 K
Slightly volatile
Other Current LiabilitiesM1.3 M1.1 M
Slightly volatile
Other Liabilities281.2 K218.7 K256.6 K
Slightly volatile

Omnimmune Holdings Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.9 M1.8 M1.5 M
Slightly volatile

Omnimmune Holdings Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock972K83.9 K
Slightly volatile
Net Borrowings421.6 K234.9 K239.5 K
Pretty Stable
Total Cash From Financing Activities224.4 K236.3 K311.8 K
Slightly volatile
Depreciation19.1 K20.1 K420.3 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.580.650.7073
Slightly volatile
Average Payables567.7 K638.7 K697.1 K
Slightly volatile
EV To Sales1.7 K1.9 K2.1 K
Slightly volatile
ROIC2.943.313.6158
Slightly volatile
Cash Per Share7.0E-47.0E-40.001
Slightly volatile
Intangibles To Total Assets0.02120.02380.026
Slightly volatile
Current Ratio0.00780.00820.1429
Slightly volatile
Revenue Per Share1.0E-41.0E-41.0E-4
Slightly volatile
Interest Debt Per Share0.310.330.289
Slightly volatile
Debt To Assets76.3883.1674.417
Pretty Stable
Ebt Per Ebit0.870.981.074
Slightly volatile
Quick Ratio0.00780.00820.1429
Slightly volatile
Cash Ratio0.00140.00150.1373
Slightly volatile
Debt Ratio76.3883.1674.417
Pretty Stable
Price Sales Ratio0.580.650.7073
Slightly volatile
Asset Turnover0.03490.03920.0428
Slightly volatile

Omnimmune Holdings Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap786K896
Pretty Stable

About Omnimmune Holdings Financial Statements

Investors use fundamental indicators, such as Omnimmune Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Omnimmune Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Ebit Per Revenue(96.29)(101.10)

Currently Active Assets on Macroaxis

When determining whether Omnimmune Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omnimmune Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omnimmune Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omnimmune Holdings Stock:
Check out the analysis of Omnimmune Holdings Correlation against competitors.
For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnimmune Holdings. If investors know Omnimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnimmune Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(20.76)
The market value of Omnimmune Holdings is measured differently than its book value, which is the value of Omnimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Omnimmune Holdings' value that differs from its market value or its book value, called intrinsic value, which is Omnimmune Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnimmune Holdings' market value can be influenced by many factors that don't directly affect Omnimmune Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnimmune Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnimmune Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.